Boone Trail Optometric Eye Care, Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 48 Boone Trl, North Wilkesboro, NC 28659 Phone: 336-667-3288 Fax: 336-838-1092 |
Eyecarecenter Od Pa Optometrist Medicare: Not Enrolled in Medicare Practice Location: 190 Independence Ave Ste A, North Wilkesboro, NC 28659 Phone: 336-667-6782 Fax: 336-667-7968 |
Dr. Zophia Rendon, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 316 Main St, North Wilkesboro, NC 28659 Phone: 336-667-6782 Fax: 336-667-7968 |
Dr. Danny J Payne, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 525 W Park Cir, North Wilkesboro, NC 28659 Phone: 336-838-5852 |
George S. Mccarter, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 316 Main St, North Wilkesboro, NC 28659 Phone: 336-667-6782 Fax: 336-667-7968 |
Sandra Love Swaringen, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 48 Boone Trl, North Wilkesboro, NC 28659 Phone: 336-667-3288 Fax: 336-838-1092 |
Robert B. Taylor, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 826 C Street, North Wilkesboro, NC 28659 Phone: 336-838-2281 Fax: 336-667-3761 |
Megan B Swaringen, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 48 Boone Trl, North Wilkesboro, NC 28659 Phone: 336-667-3288 Fax: 336-838-1092 |
News Archive
The bacterium Helicobacter pylori is strongly associated with gastric ulcers and cancer. To combat the infection, researchers at University of California, San Diego School of Medicine and Jacobs School of Engineering developed LipoLLA, a therapeutic nanoparticle that contains linolenic acid, a component in vegetable oils.
But North Dakota became the first state to have the Department of Health and Human Services deny a waiver request regarding the health law's medical loss ratio provision, which requires health plans in the individual and small-group markets to spend no more than 20 percent of premiums on administrative costs.
Daylight Solutions, Inc., a leading manufacturer of molecular detection and imaging solutions in the mid-infrared, today announced the launch of the world's first commercially available laser-based infrared microscopy platform.
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
› Verified 3 days ago